Radiotherapy Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Image

Radiotherapy Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4333239
  • Report
  • Region: Global
  • 140 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Accuray Incorporated
  • C. R. Bard, Inc.
  • Elekta Ab
  • Isoray Medical, Inc.
  • Nordion, Inc.
  • Raysearch Laboratories Ab
  • MORE
Radiotherapy is also known as radiation therapy, which utilizes high-energy radiation to kill cancer cells and reduce tumors. It involves the use of various rays including X-rays, gamma rays, and charged particles. During radiotherapy, radiation can be delivered to the body tissues internally as well as externally. According to the National Cancer Institute, around half of all the cancer patient population receives some type of radiation therapy during their treatment.

The global radiotherapy market was valued at $4,723 million in 2016, and is expected to reach at $7,222 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, owing to surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, lack of skilled personnel and difficulty in tumor visualization restrict the market growth. Conversely, growth opportunities in emerging markets and rise in demand for cancer treatment are expected to provide several opportunities for market growth during the forecast period.

The report segments the market based on type, end user, and region. Based on type, it is divided into external beam radiation therapy, internal radiation therapy/brachytherapy, and systemic radiation therapy. Based on end user, it is categorized into hospitals & clinics and ambulatory surgical centers. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Colombia, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis by type helps to understand the various types of devices used for radiotherapy.
Key players are profiled and their strategies are analyzed thoroughly to understand competitive outlook of the global market.

KEY MARKET SEGMENTS

BY TYPE

External Beam Radiation Therapy

By Product
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
Tomotherapy
Proton Therapy Systems
Conventional Radiotherapy Systems

By Technology

Image-Guided Radiotherapy (IGRT)
Intensity Modulated Radiotherapy (IMRT)
Stereotactic Technology
Proton Beam Therapy
3D Conformal Radiotherapy (3D CRT)
Volumetric Modulated Arc Therapy (VMAT)

By Application

Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Other
Internal Radiation Therapy/Brachytherapy

By Product

Seeds & Applicators
Electronic Brachytherapy

By Technology

Low Dose Rate
High Dose Rate

By Application

Prostate Cancer
Gynecological Cancer
Breast Cancer
Other
Systemic Radiation Therapy

BY END USER

Hospitals & Clinics
Ambulatory Surgical Centers

BY REGION

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT

Varian Medical Systems, Inc.
Elekta AB
Accuray Incorporated
IBA (Ion Beam Applications Sa)
Nordion, Inc.
C. R. Bard, Inc.
Isoray Medical, Inc.
Raysearch Laboratories AB
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Shenzhen GeneMDx Biotech. Co., Ltd.
Vision RT Ltd.
IntraOp Medical, Inc.
Eckert & Ziegler
Theragenics Corporation
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accuray Incorporated
  • C. R. Bard, Inc.
  • Elekta Ab
  • Isoray Medical, Inc.
  • Nordion, Inc.
  • Raysearch Laboratories Ab
  • MORE
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing number of cancer patients
3.4.1.2. Increasing ageing population
3.4.1.3. Rising awareness and increasing adoption of radiotherapy devices and procedures
3.4.1.4. Technological advancements in radiotherapy devices

3.4.2. Restraints

3.4.2.1. Dearth of skilled personnel
3.4.2.2. Difficulty in tumor visualization

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increasing demand for cancer treatment

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL RADIOTHERAPY MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EXTERNAL BEAM RADIATION THERAPY

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. External beam radiation therapy market, by product
4.2.5. Market size and forecast

4.2.5.1. Compact advanced radiotherapy systems

4.2.5.1.1. Market size and forecast
4.2.5.1.2. CyberKnife

4.2.5.1.2.1. Market size and forecast

4.2.5.1.3. Gamma Knife

4.2.5.1.3.1. Market size and forecast

4.2.5.1.4. Tomotherapy

4.2.5.1.4.1. Market size and forecast

4.2.5.2. Proton therapy systems

4.2.5.2.1. Market size and forecast

4.2.5.3. Conventional radiotherapy systems

4.2.5.3.1. Market size and forecast

4.2.6. External beam radiation therapy, by technology
4.2.7. Market size and forecast

4.2.7.1. 3D Conformal Radiotherapy (3D CRT)

4.2.7.1.1. Market size & forecast

4.2.7.2. Image-Guided Radiotherapy (IGRT)

4.2.7.2.1. Market size & forecast

4.2.7.3. Intensity Modulated Radiotherapy (IMRT)

4.2.7.3.1. Market size & forecast

4.2.7.4. Stereotactic Technology

4.2.7.4.1. Market size & forecast

4.2.7.5. Proton Beam Therapy

4.2.7.5.1. Market size & forecast

4.2.7.6. Volumetric Modulated Arc Therapy (VMAT)

4.2.7.6.1. Market size & forecast

4.2.8. External beam radiation therapy, by application
4.2.9. Market size & forecast

4.2.9.1. Prostate Cancer

4.2.9.1.1. Market size & forecast

4.2.9.2. Breast Cancer

4.2.9.2.1. Market size & forecast

4.2.9.3. Lung Cancer

4.2.9.3.1. Market size & forecast

4.2.9.4. Colorectal Cancer

4.2.9.4.1. Market size & forecast

4.2.9.5. Other

4.2.9.5.1. Market size & forecast

4.3. INTERNAL RADIATION THERAPY/BRACHYTHERAPY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Brachytherapy market, by product
4.3.5. Market size and forecast

4.3.5.1. Implants & applicators

4.3.5.1.1. Market size and forecast

4.3.5.2. Electronic brachytherapy devices

4.3.5.2.1. Market size and forecast

4.3.6. Brachytherapy market, by technology
4.3.7. Market size and forecast

4.3.7.1. Low dose rate

4.3.7.1.1. Market size and forecast

4.3.7.2. High dose rate

4.3.7.2.1. Market size and forecast

4.3.8. Brachytherapy market, by application
4.3.9. Market size and forecast

4.3.9.1. Prostate cancer

4.3.9.1.1. Market size and forecast

4.3.9.2. Gynecological cancer

4.3.9.2.1. Market size and forecast

4.3.9.3. Breast cancer

4.3.9.3.1. Market size and forecast

4.3.9.4. Other

4.3.9.4.1. Market size and forecast

4.4. SYSTEMIC RADIATION THERAPY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 RADIOTHERAPY MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS (ASCS)

5.3.1. Market size and forecast

CHAPTER 6 RADIOTHERAPY MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

7.1. ACCURAY INCORPORATED

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.7. Key strategic moves and developments

7.2. C. R. BARD, INC.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments

7.3. ELEKTA AB

7.3.1. Company overview
7.3.2. Company Snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.7. Key strategic moves and developments

7.4. IBA (ION BEAM APPLICATIONS SA)

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Key strategic moves and developments

7.5. ISORAY MEDICAL, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.7. Key strategic moves and developments

7.6. MEVION MEDICAL SYSTEMS, INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.7. Key strategic moves and developments

7.7. MITSUBISHI ELECTRIC CORPORATION

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments

7.8. NORDION, INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Key strategic moves and developments

7.9. RAYSEARCH LABORATORIES AB

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating product categories
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. VARIAN MEDICAL SYSTEMS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accuray Incorporated
  • C. R. Bard, Inc.
  • Elekta Ab
  • Isoray Medical, Inc.
  • Nordion, Inc.
  • Raysearch Laboratories Ab
  • MORE
According to a new report titled, Radiotherapy Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global radiotherapy market was valued at $4,723million in 2016, and is projected to reach at $7,222million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The external beam radiation therapy segment accounted for more than four-fifths of the total market in 2016.

Radiotherapy devices are used to treat cancer patients by exposing the cancerous tissues to X-rays, gamma rays, and charged particles. The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, owing to surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, dearth of skilled personnel and difficulty in tumor visualization restrict the market growth. Furthermore, growth opportunities in emerging markets and increase in demand for cancer treatment are expected to provide numerous opportunities for market growth during the forecast period.
The external beam radiation therapy segment is expected to maintain its dominant position throughout the analysis period, due to rise in the demand for radiotherapy procedures and the increased incidence of different types of cancers. In addition, brachytherapy segment is expected to grow at a high CAGR of 9.9% from 2017 to 2023.

Key Findings of the Radiotherapy Market:
The external beam radiation therapy segment accounted for more than four-fifths of the total market in 2016.
The hospitals segment accounted for more than three-fifths of the total market in 2016.
Asia-Pacific is expected grow at the highest CAGR of 7.5% from 2017 to 2022
North America accounted for majority of the share (nearly two-fifths) in the market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to increased adoption of radiotherapy devices, enhanced technological advancements, and development of novel products by the key players. In addition, rise in the elderly population, favorable reimbursement rates, prevalence of different types of cancers, and advanced healthcare infrastructure fuel the market growth.
The major companies profiled in the report include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, IBA (Ion Beam Applications SA), Nordion, Inc., C. R. Bard, Inc., Isoray Medical, Inc., Raysearch Laboratories AB, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation.
Note: Product cover images may vary from those shown
5 of 5
  • Varian Medical Systems, Inc.
  • Elekta Ab
  • Accuray Incorporated
  • Iba (Ion Beam Applications Sa)
  • Nordion, Inc.
  • C. R. Bard, Inc.
  • Isoray Medical, Inc.
  • Raysearch Laboratories Ab
  • Mevion Medical Systems, Inc.
  • Mitsubishi Electric Corporation
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll